Administrative Core

行政核心

基本信息

  • 批准号:
    8820830
  • 负责人:
  • 金额:
    $ 12.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-03-01 至 2016-02-29
  • 项目状态:
    已结题

项目摘要

The Administrative Core is the glue that binds together this application for a Center of Excellence Grant (COE) in prostate cancer disparities. The Core will provide Administrative support and oversight for the Program's research. Its major objectives are leadership and management of Program activities, communication, training, quality assurance, and strategic planning. The Administrative Core will coordinate all COE activities and set general policies. It will be responsible for managing the day-to-day operations of the COE and for providing assistance to Core Directors and Project Principal Investigators in administering their units. It will do so through a senior management structure made up of a Steering Committee, Executive Committee, Community Advisory Board, and External Advisory Board. The Administrative Core will be directly responsible for budgeting and business office support for all Projects and Cores, interface with and preparation of reports to NCI staff, provision of clerical support for Projects and Cores, coordination of Administrative support, and overall coordination of scientific activities. In addition, the Administrative Core will support ongoing contact among the investigators, and will provide written progress reports as the Projects proceed. The co-Directors of the Administrative Core will be responsible for overseeing the performance of each of the service Cores and assuring quality and cost-effectiveness of the services. Finally, the Administrative Core will also be responsible for determining the research direction of the COE. A major aspect of this direction will be the selection and evaluation of new transdisciplinary, translational science and training of the next generation of health disparities researchers. As the current group of Projects proceeds, there will be a need to decide whether to support grant applications for supplemental funds. If so, then priorities will need to be set among these other possibilities. This will be a responsibility of the Administrative Core, with guidance from its Steering and Advisory Committees. Analogously, as the current group of Projects approaches completion, there will need to be a decision about whether to apply for a renewal of this Program and, if so, the Projects and investigators to be included. Again, this will be a responsibility of the Administrative Core.
行政核心是将该应用程序绑架为前列腺癌差异的卓越赠款(COE)的胶水。核心将为该计划的研究提供行政支持和监督。它的主要目标是对计划活动,沟通,培训,质量保证和战略计划的领导和管理。 行政核心将协调所有COE活动并制定一般政策。这将是 负责管理COE的日常运营,并为核心董事和项目首席调查人员提供帮助,以管理其单位。它将通过由指导委员会,执行委员会,社区顾问委员会和外部顾问委员会组成的高级管理结构来做到这一点。行政核心将直接负责所有项目和核心的预算和业务办公室支持,与NCI员工的报告并准备报告,提供有关项目和核心的文书支持,行政支持的协调以及科学活动的整体协调。此外,行政核心将支持调查人员之间的持续联系,并将随着项目的进行提供书面进度报告。行政核心的联合导演将负责监督每个服务核心的性能,并确保服务的质量和成本效益。 最后,行政核心还将负责确定COE的研究方向。这个方向的一个主要方面将是对下一代健康差异研究人员的新跨学科,转化科学和培训的选择和评估。随着当前项目的进行,将需要决定是否支持补充资金的赠款申请。如果是这样,则需要在这些其他可能性中设定优先级。在其转向和咨询委员会的指导下,这将是行政核心的责任。 类似地,随着当前项目的完成组的完成,将需要做出决定是否申请该计划的续订,如果是的,则需要包括项目和调查人员。 同样,这将是行政核心的责任。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TIMOTHY R REBBECK其他文献

TIMOTHY R REBBECK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TIMOTHY R REBBECK', 18)}}的其他基金

Genomic Diversity of Prostate Cancer Across the African Diaspora
非洲侨民前列腺癌的基因组多样性
  • 批准号:
    10548218
  • 财政年份:
    2022
  • 资助金额:
    $ 12.89万
  • 项目类别:
Genomic Diversity of Prostate Cancer Across the African Diaspora
非洲侨民前列腺癌的基因组多样性
  • 批准号:
    10364057
  • 财政年份:
    2022
  • 资助金额:
    $ 12.89万
  • 项目类别:
BIDIRECTIONAL TRAINING TO ENHANCE CANCER RESEARCH CAPACITY IN AFRICA
加强非洲癌症研究能力的双向培训
  • 批准号:
    10223596
  • 财政年份:
    2021
  • 资助金额:
    $ 12.89万
  • 项目类别:
BIDIRECTIONAL TRAINING TO ENHANCE CANCER RESEARCH CAPACITY IN AFRICA
加强非洲癌症研究能力的双向培训
  • 批准号:
    10597079
  • 财政年份:
    2021
  • 资助金额:
    $ 12.89万
  • 项目类别:
BIDIRECTIONAL TRAINING TO ENHANCE CANCER RESEARCH CAPACITY IN AFRICA
加强非洲癌症研究能力的双向培训
  • 批准号:
    10401899
  • 财政年份:
    2021
  • 资助金额:
    $ 12.89万
  • 项目类别:
Research Traiing/Education Core
研究培训/教育核心
  • 批准号:
    9013501
  • 财政年份:
    2016
  • 资助金额:
    $ 12.89万
  • 项目类别:
Genetics of Prostate Cancer in Africa
非洲前列腺癌的遗传学
  • 批准号:
    9139465
  • 财政年份:
    2015
  • 资助金额:
    $ 12.89万
  • 项目类别:
Genetics of Prostate Cancer in Africa
非洲前列腺癌的遗传学
  • 批准号:
    9756326
  • 财政年份:
    2015
  • 资助金额:
    $ 12.89万
  • 项目类别:
Research Traiing/Education Core
研究培训/教育核心
  • 批准号:
    8820832
  • 财政年份:
    2015
  • 资助金额:
    $ 12.89万
  • 项目类别:
Molecular Epidemiology of Prostate Cancer Outcomes: Genetics, Multilevel Environ
前列腺癌结果的分子流行病学:遗传学、多层次环境
  • 批准号:
    8820827
  • 财政年份:
    2015
  • 资助金额:
    $ 12.89万
  • 项目类别:

相似海外基金

Administrative Core
行政核心
  • 批准号:
    10716153
  • 财政年份:
    2023
  • 资助金额:
    $ 12.89万
  • 项目类别:
Center for 3D Imaging in Cancer Cell Biology
癌细胞生物学 3D 成像中心
  • 批准号:
    10375191
  • 财政年份:
    2021
  • 资助金额:
    $ 12.89万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10194364
  • 财政年份:
    2020
  • 资助金额:
    $ 12.89万
  • 项目类别:
CORALE-SeroNet Admin Core
CORALE-SeroNet 管理核心
  • 批准号:
    10222433
  • 财政年份:
    2020
  • 资助金额:
    $ 12.89万
  • 项目类别:
Admin Core - Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
管理核心 - 自噬调节剂作为新型广谱抗感染剂
  • 批准号:
    9893810
  • 财政年份:
    2020
  • 资助金额:
    $ 12.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了